Table 3.
Relative risks (95% confidence intervals) associated with every 1 mmol/L reduction in LDL-C achieved with statins[8]
| Outcome | Relative risk |
|---|---|
| All-cause mortality | 0.88 (0.84–0.91) |
| Coronary mortality | 0.81 (0.76–0.85) |
| Myocardial infarction or coronary death | 0.77 (0.74–0.80) |
| Coronary vascularisation | 0.76 (0.73–0.80) |
| Stroke (non-fatal and fatal) | 0.83 (0.78–0.88) |
| Major cardiovascular eventa | 0.79 (0.77–0.81) |
aComposite of myocardial infarction or coronary death, coronary vascularisation and stroke